IPHA

INNATE PHARMA S A SPONSORED ADS

IPHA·45781K204·US·ADR·Healthcare - Biotechnology-13D/G

IPHA (INNATE PHARMA S A SPONSORED ADS) is held by 7 institutional investors as of Q2 2026. Largest holders: MORGAN STANLEY ($80,084), XTX Topco Ltd ($27,839), CITADEL ADVISORS LLC ($22,891). Net institutional sentiment: Mixed.

7
Holders
$161,012
Total Value
57% (7)
Consensus
4 buying - 3 selling
13F: Insider & Congress: Updated regularly
IPHA

Smart Money Verdict

View all
Loading verdict
Held by 7 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists Apr 10, 2026 · Congress none

ActivistNNNovo Nordisk A/S5.0%Apr 10, 2026

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
43,524$80,0840.0%+12.39%
0
New
15,130$27,8390.0%+17.39%
27
New
12,441$22,8910.0%+17.39%
29
Decreased
10,310(-76.2%)$18,9710.0%+24.14%
0
Decreased
4,719(-0.3%)$8,6810.0%+20.58%
0
Increased
1,363(+58.3%)$2,5080.0%+8.74%
12
Increased
21(+110.0%)$380.0%+18.00%
12
Exited
0(-100.0%)$12,8820.0%+5.75%
0
IPHAIPHAINNATE PHARMA S A SPONSORED ADS

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used